VANCOUVER, British Columbia, March 16, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“Syarikat” atau “Algernon”) […]
VANCOUVER, British Columbia, March 16, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (das „Unternehmen“ oder […]
VANCOUVER, Colombie-Britannique, 16 mars 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE : AGN) (FRANCFORT : AGW) (OTCQB : AGNPF) (la « société » ou [...]
卑詩省溫哥華, March 16, 2020 (GLOBE NEWSWIRE) — 臨床階段藥物開發公司Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF)（簡稱「公司」或「Algernon」）欣然宣佈已向美國 FDA 提交其新藥研究審查前會議申請。此舉將啟動與美國 FDA [...]
不列颠哥伦比亚省温哥华, March 16, 2020 (GLOBE NEWSWIRE) — 临床阶段药品开发公司Algernon Pharmaceuticals Inc. （CSE: AGN）（FRANKFURT: AGW）（OTCQB: [...]
Signs Cooperation Agreement with Seville City GovernmentAerial Light Show Will Celebrate 500th Anniversary of Magellan VoyageWill Promote the Commercialization of […]
HOLLYWOOD, Fla., March 16, 2020 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of […]
